CN Stock MarketDetailed Quotes

688578 Shanghai Allist Pharmaceuticals Co., Ltd.

Watchlist
  • 63.43
  • +3.35+5.58%
Market Closed Dec 11 15:00 CST
28.54BMarket Cap22.01P/E (TTM)

Shanghai Allist Pharmaceuticals Co., Ltd. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Shanghai Allist Pharmaceuticals Co., Ltd. Q3 2024 Earnings Date

Currency：CNYOct 25, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
957.00M
--
+59.73%
EPS
--
0.90
--
--
Analyst Rating
Strong Buy

Dec 11, 2024

Shanghai Allist Pharmaceuticals Co., Ltd. Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 4.214B--
--2024/FY-- / 3.424B--
--2023/FY2.012B / 1.777B--
--2021/FY530.094M / 614.000M--
--2020/FY560.900K / 600.000K--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 4.214B--
--2024/FY-- / 3.424B--
--2023/FY2.012B / 1.777B--
--2021/FY530.094M / 614.000M--
--2020/FY560.900K / 600.000K--

Unlock Free Earnings Estimates

Shanghai Allist Pharmaceuticals Co., Ltd. Earnings Reports

  • Shanghai Alice Pharmaceutical Technology Co., Ltd. Report for the Third Quarter of 2024

    Oct 24 12:00 ET

  • Shanghai Allist Pharmaceuticals Co., Ltd. Semi-Annual Report 2024

    Aug 20 12:00 ET

  • Shanghai Allist Pharmaceuticals Co., Ltd. half-year report summary for 2024.

    Aug 20 12:00 ET

  • Shanghai Alice Pharmaceutical Technology Co., Ltd. 2024 First Quarter Report

    Apr 25 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 11, 2024

    Strong Buy

    • Strong Buy

      71.43%

    • Buy

      28.57%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data